Schedule 13G ownership disclosure
Celladon Corp
Security class unavailable · CUSIP: 15117E107
Event date: 2015-04-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,367,687
- Percent of class
- 5.7900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019687-15-001528
- Form type
- SC 13G
- Filer
- Eiger BioPharmaceuticals, Inc.
- CIK
- CIK 1305253
- Filed
- Apr 20, 2015
- Reporting period
- Apr 16, 2015
- Description
- Schedule 13G beneficial ownership